{
    "nct_id": "NCT04402788",
    "official_title": "RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial",
    "brief_title": "Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial",
    "cancer_type_display": "A study for patients with extensive stage small cell lung cancer who have responded to initial chemotherapy and immunotherapy.",
    "cancer_tags": [
      "Extensive Stage Lung Small Cell Carcinoma"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT04402788",
    "phase": "Phase 2/Phase 3",
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-10-31",
    "enrollment": 138,
    "min_age": 18,
    "max_age": null,
    "sex": "ALL",
    "is_metastatic_allowed": true,
    "performance_status_scale": "ECOG",
    "performance_status_values": [
      0,
      1,
      2
    ],
    "min_prior_lines": null,
    "max_prior_lines": null,
    "prior_treatments_required": [
      "4-6 cycles of etoposide/platinum (E/P) doublet plus atezolizumab"
    ],
    "prior_treatments_excluded": [
      "Prior radiotherapy in the thorax that would result in overlapping RT fields",
      "Prior immunotherapy that resulted in pneumonitis"
    ],
    "principal_investigator": "Quynh-Nhu Nguyen",
    "site_name": null,
    "contact_email": null,
    "contact_phone": null,
    "locations": null,
    "key_inclusion_summary": [
      "Confirmed diagnosis of extensive stage small cell lung cancer.",
      "Must have achieved a partial response or stable disease after 4-6 cycles of etoposide/platinum chemotherapy plus atezolizumab.",
      "Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
      "Patients with treated, stable brain metastases are eligible.",
      "Measurable disease per RECIST criteria."
    ],
    "key_exclusion_summary": [
      "Metastatic disease involving > 3 liver metastases, the heart, or > 10 total metastatic sites.",
      "Active autoimmune disease requiring immunosuppressive treatment.",
      "Prior radiotherapy to the thorax that would cause overlapping radiation fields.",
      "History of immunotherapy-induced pneumonitis.",
      "Pregnancy or breastfeeding."
    ]
  }